Personalized management in low-risk prostate cancer: the role of biomarkers.
about
Circulating microRNA signature for the diagnosis of very high-risk prostate cancerMicrofluidic platforms for biomarker analysis.Biomarkers and personalized risk stratification for patients with clinically localized prostate cancer.Increased aPKC Expression Correlates with Prostatic Adenocarcinoma Gleason Score and Tumor Stage in the Japanese Population.Future prospects in the diagnosis and management of localized prostate cancer.
P2860
Personalized management in low-risk prostate cancer: the role of biomarkers.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Personalized management in low-risk prostate cancer: the role of biomarkers.
@ast
Personalized management in low-risk prostate cancer: the role of biomarkers.
@en
type
label
Personalized management in low-risk prostate cancer: the role of biomarkers.
@ast
Personalized management in low-risk prostate cancer: the role of biomarkers.
@en
prefLabel
Personalized management in low-risk prostate cancer: the role of biomarkers.
@ast
Personalized management in low-risk prostate cancer: the role of biomarkers.
@en
P2093
P2860
P356
P1433
P1476
Personalized management in low-risk prostate cancer: the role of biomarkers
@en
P2093
Agus Rizal A H Hamid
Gisèle H J M Leyten
Jack A Schalken
P2860
P304
P356
10.1155/2012/327104
P577
2012-12-13T00:00:00Z